Mirae Asset Global ETFs Holdings
SLDB icon

Mirae Asset Global ETFs Holdings’s Solid Biosciences SLDB Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Buy
44,574
+16,550
+59% +$125K ﹤0.01% 2077
2026
Q1 		$202K Buy
28,024
+680
+2% +$4.37K ﹤0.01% 2358
2025
Q4 		$154K Sell
27,344
-48
-0.2% -$260 ﹤0.01% 2470
2025
Q3 		$169K Sell
27,392
-8,751
-24% -$51.2K ﹤0.01% 2406
2025
Q2 		$176K Buy
36,143
+22,663
+168% +$80.1K ﹤0.01% 2346
2025
Q1 		$49.9K Buy
13,480
+577
+4% +$2.47K ﹤0.01% 2850
2024
Q4 		$51.6K Buy
12,903
+532
+4% +$2.92K ﹤0.01% 2897
2024
Q3 		$86.2K Buy
+12,371
New +$100K ﹤0.01% 2775

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's SLDB Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Solid Biosciences (SLDB) stake by 59% in Q2 2026, buying an estimated $125K and bringing the position to 44,574 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Mirae Asset Global ETFs Holdings first reported a position in SLDB in Q3 2024 and has held it in 8 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 44,574 shares of Solid Biosciences worth $441K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 16,550 Solid Biosciences shares in Q2 2026, an estimated $125K.
  • Solid Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2077 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Solid Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.